132 related articles for article (PubMed ID: 37802317)
1. Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.
Lee DC; Schlienz NJ; Herrmann ES; Martin EL; Leoutsakos J; Budney AJ; Smith MT; Tompkins DA; Hampson AJ; Vandrey R
J Subst Use Addict Treat; 2024 Jan; 156():209180. PubMed ID: 37802317
[TBL] [Abstract][Full Text] [Related]
2. Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal.
Vandrey R; Smith MT; McCann UD; Budney AJ; Curran EM
Drug Alcohol Depend; 2011 Aug; 117(1):38-44. PubMed ID: 21296508
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
[TBL] [Abstract][Full Text] [Related]
4. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
[TBL] [Abstract][Full Text] [Related]
5. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.
Morin CM; Vallières A; Guay B; Ivers H; Savard J; Mérette C; Bastien C; Baillargeon L
JAMA; 2009 May; 301(19):2005-15. PubMed ID: 19454639
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
7. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
8. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Zolpidem in the treatment of insomnia disorder for one month: a meta-analysis of a randomized controlled trial.
Xiang T; Cai Y; Hong Z; Pan J
Sleep Med; 2021 Nov; 87():250-256. PubMed ID: 34688027
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
11. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
13. Sequential psychological and pharmacological therapies for comorbid and primary insomnia: study protocol for a randomized controlled trial.
Morin CM; Edinger JD; Krystal AD; Buysse DJ; Beaulieu-Bonneau S; Ivers H
Trials; 2016 Mar; 17(1):118. PubMed ID: 26940892
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings.
Inoue Y; Nishida M; Kubota N; Koebis M; Taninaga T; Muramoto K; Ishikawa K; Moline M
J Clin Sleep Med; 2023 Mar; 19(3):519-528. PubMed ID: 36472134
[TBL] [Abstract][Full Text] [Related]
16. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.
Bhardwaj AK; Mills L; Doyle M; Sahid A; Montebello M; Monds L; Arunogiri S; Haber P; Lorenzetti V; Lubman DI; Malouf P; Harrod ME; Dunlop A; Freeman T; Lintzeris N
BMC Psychiatry; 2024 Mar; 24(1):175. PubMed ID: 38433233
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
18. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
[TBL] [Abstract][Full Text] [Related]
19. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Fava M; Asnis GM; Shrivastava R; Lydiard B; Bastani B; Sheehan D; Roth T
J Clin Psychopharmacol; 2009 Jun; 29(3):222-30. PubMed ID: 19440075
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem.
Beaulieu-Bonneau S; Ivers H; Guay B; Morin CM
Sleep; 2017 Mar; 40(3):. PubMed ID: 28364426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
